Subject(s)
Chlamydia Infections/nursing , Chlamydia trachomatis , Communicable Disease Control , Sexually Transmitted Diseases, Bacterial/nursing , Chlamydia Infections/diagnosis , Chlamydia Infections/prevention & control , Female , Humans , Male , Sexually Transmitted Diseases, Bacterial/diagnosis , Sexually Transmitted Diseases, Bacterial/prevention & controlSubject(s)
Gonorrhea , Female , Gonorrhea/diagnosis , Gonorrhea/microbiology , Gonorrhea/nursing , Humans , Male , Primary Prevention/methodsSubject(s)
Aspergillosis/diagnosis , Aspergillosis/nursing , Lung Diseases, Fungal/diagnosis , Lung Diseases, Fungal/nursing , Aspergillosis/blood , Aspergillosis/drug therapy , Aspergillus/pathogenicity , Humans , Lung Diseases, Fungal/blood , Lung Diseases, Fungal/drug therapy , Patient Care Planning , Primary PreventionABSTRACT
Learn the signs and symptoms of Clostridium difficile-associated diarrhea (CDAD), outline infection control measures to help stop its spread and review treatment regimens.
Subject(s)
Clostridioides difficile , Clostridium Infections , Cross Infection , Diarrhea , Enterocolitis, Pseudomembranous , Infection Control/methods , Anti-Bacterial Agents/adverse effects , Causality , Clostridium Infections/diagnosis , Clostridium Infections/etiology , Clostridium Infections/therapy , Cross Infection/diagnosis , Cross Infection/etiology , Cross Infection/therapy , Diarrhea/diagnosis , Diarrhea/etiology , Diarrhea/therapy , Enterocolitis, Pseudomembranous/diagnosis , Enterocolitis, Pseudomembranous/etiology , Enterocolitis, Pseudomembranous/therapy , Humans , Incidence , Nurse's Role , Recurrence , Universal PrecautionsABSTRACT
Are you unwittingly contributing to the spread of these dangerous antibiotic-resistant organisms? Learn to protect your patients--and yourself--from out-of-control infections.
Subject(s)
Cross Infection/prevention & control , Enterococcus , Gram-Positive Bacterial Infections/prevention & control , Infection Control/methods , Methicillin Resistance , Staphylococcal Infections/prevention & control , Staphylococcus aureus , Vancomycin Resistance , Cross Infection/microbiology , Gram-Positive Bacterial Infections/microbiology , Humans , Risk Factors , Staphylococcal Infections/microbiologySubject(s)
Clostridioides difficile , Clostridium Infections/prevention & control , Cross Infection/prevention & control , Diarrhea/prevention & control , Infection Control/methods , Clostridium Infections/etiology , Clostridium Infections/nursing , Cross Infection/etiology , Cross Infection/nursing , Diarrhea/etiology , Diarrhea/nursing , Humans , Risk FactorsABSTRACT
Periodic quantitative HIV-1 plasma cultures were performed on 28 seropositive individuals who had CD4 cells < or = 300/mm3 and who were enrolled in three clinical trials testing the efficacy of didanosine versus zidovudine monotherapy. Most plasma cultures were negative or of low titer (1-100 tissue culture infective dose/ml of plasma), but there were 14 instances of high-titered plasma viremia (> or = 1,000 tissue culture infective dose/ml of plasma) seen in 11 individuals. These peaks in plasma culture titers were significantly associated either with rapidly decreasing CD4 cell numbers or with CD4 cells already < 50/mm3. In addition, patients who experienced these episodes of high-titered plasma viremia were more apt to have clinical complaints of fever, rash, flu-like illness, and/or opportunistic infection and also the syncytium-inducing HIV-1 phenotype and progression of disease.
